United States Federal Circuit

ResetAA Font size: Print

UCB, Inc. v. Accord Healthcare, Inc., 16-2610

Affirming the district court's conclusion that asserted claims relating to lacosamide, a class of functionalized amino acid compounds, are not invalid and that the court applied the correct legal standards in its obviousness, double patenting, and anticipation analyses.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2018/05/23




  • United States Federal Circuit


FindLaw Career Center

    Select a Job Title

      Post a Job  |  Careers Home

    View More